REACH XVII Restriction on Microplastic
January 06, 2026
The European Commission has published a draft amendment to Annex XVII of the REACH Regulation addressing restrictions on synthetic polymer microparticles (SPMs), commonly referred to as microplastics. The proposal updates elements of Regulation (EU) 2023/2055 and focuses on improving clarity and implementation.
Key proposed changes include expanding exemptions for medicinal products to cover SPMs used in clinical trials and pre-clinical testing. The draft also introduces an exemption for product and process-oriented research and development (PPORD), including activities carried out in hospitals and academic settings. The aim of proposed adjustments is to support the broader goal of reducing environmental emissions of microplastics.
Other News You May Be Interested In
August 10, 2026
EU proposes harmonised end-of-waste criteria for recycled plastic
August 10, 2026
Japan's PFHxS restriction enters into force, confirming import ban on treated products
August 10, 2026
UK explores its own Digital Product Passport (DPP) record policy, with call for evidence open until September
<strong>Stay informed. </strong>Get the latest regulatory updates, compliance insights, and CDX news delivered to your inbox.
Subscribe to our Newsletter
👋 Do you have questions about CDX? I'm an AI chatbot and I'm happy to help.
CDX AI Assistant
Do you have questions about CDX? I'm an AI chatbot and I'm happy to help. Please do not enter any personal information to the chatbot like User ID, Company ID or passwords. In case you think your personal information are essential to your problem, please contact the user support via
cdx-servicedesk@dxc.com.
Ask me a question or choose one of the following options:
cdx-servicedesk@dxc.com.
Ask me a question or choose one of the following options:
AI-generated content may be inaccurate. By messaging, you agree to our
Privacy Policy